Themis Medicare Ltd Detail
Themis Medicare Ltd is in portfolio of Anuj Anantrai Sheth. He is one of the top investors in India. The company belongs to Pharma sector.
As per the Company website it is an Pharma Company mainly dealing with API. It deals with Injectable. The Company was founded as joint venture with Gedeon Richter Ltd. Hungary. Below are some products from the Company
- Emal – the first in the world injectable against critical malaria
- Etojet – the worlds first painless Etrocoxib injection and a first of its kinds injectable.
- Diclofenac sodium for pain relief
It has divided its operations in below verticals
- API capabilities
- Anti Malaria
- Specialty Division
- CCD Products
- Nutritional Gummies and Candy
- Other Products
I have shared long term price performance chart of the Company below.As per Dow theory of technical analysis price performance over a period of time reflects Company state.
English Video
Hindi Video
Themis Medicare Ltd Stock Performance
The stock has given ten times return on an absolute basis based on above long term chart. The only problem with long term price chart is that Stock does not seem to be consistent in its performance.
It has too much of ups and downs for comfort of retail investor. The price cuts were steep and for long duration rendering retail investors nervous and prompting them to come out of the investment.The stock has performed well off late but I would not suggest to get carried away with this jump.
Themis Medicare Ltd My Opinion
Themis Medicare Ltd is a Pharma Company.It has original molecule for Anti Malaria. It has dedicated section for Anti malaria injectible drug. This drug is the main driving force behind the Company.
I like Companies which innovate and create products of their own. This shows will and drive for more research and development in near future. However I was not too convinced with long term price chart. It did not give me much comfort.
Pharma as a sector has zoomed in last decade. It has given too many multi baggers in recent times. The stock has not performed well if you consider other Pharma Companies. I have already invested in Pharma sector as of this writing. I am looking to invest in one more Company.
For me this is wait and watch type of Stock. The Company seems promising in first look but is not backed with price performance. So it can be tracked now but not invested.
In case you are interested then you can track the company by adding it to your stock watch list. That way you can keep close eye on the Company.